These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Identification of TNF-alpha binding peptides from a D-amino acid hexapeptide library that specifically inhibit TNF-alpha binding to recombinant p55 receptor. Kruszynski M; Shealy DJ; Leone AO; Heavner GA Cytokine; 1999 Jan; 11(1):37-44. PubMed ID: 10080877 [TBL] [Abstract][Full Text] [Related]
23. Cytotoxic activities of recombinant soluble murine lymphotoxin-alpha and lymphotoxin-alpha beta complexes. Mackay F; Bourdon PR; Griffiths DA; Lawton P; Zafari M; Sizing ID; Miatkowski K; Ngam-ek A; Benjamin CD; Hession C; Ambrose CM; Meier W; Browning JL J Immunol; 1997 Oct; 159(7):3299-310. PubMed ID: 9317128 [TBL] [Abstract][Full Text] [Related]
24. Model complexes of tumor necrosis factor-alpha with receptors R1 and R2. Fu ZQ; Harrison RW; Reed C; Wu J; Xue YN; Chen MJ; Weber IT Protein Eng; 1995 Dec; 8(12):1233-41. PubMed ID: 8869635 [TBL] [Abstract][Full Text] [Related]
25. Crystal structure of sTALL-1 reveals a virus-like assembly of TNF family ligands. Liu Y; Xu L; Opalka N; Kappler J; Shu HB; Zhang G Cell; 2002 Feb; 108(3):383-94. PubMed ID: 11853672 [TBL] [Abstract][Full Text] [Related]
26. Ligand-receptor binding revealed by the TNF family member TALL-1. Liu Y; Hong X; Kappler J; Jiang L; Zhang R; Xu L; Pan CH; Martin WE; Murphy RC; Shu HB; Dai S; Zhang G Nature; 2003 May; 423(6935):49-56. PubMed ID: 12721620 [TBL] [Abstract][Full Text] [Related]
28. Mutational analysis of structure--activity relationships in human tumor necrosis factor-alpha. Yamagishi J; Kawashima H; Matsuo N; Ohue M; Yamayoshi M; Fukui T; Kotani H; Furuta R; Nakano K; Yamada M Protein Eng; 1990 Aug; 3(8):713-9. PubMed ID: 2217144 [TBL] [Abstract][Full Text] [Related]
29. Human tumour necrosis factors-alpha and -beta: differences in their structure, expression and biological properties. Porter AG FEMS Microbiol Immunol; 1990 Nov; 2(4):193-9. PubMed ID: 2285517 [TBL] [Abstract][Full Text] [Related]
30. Characterization of a novel human tumor necrosis factor-alpha mutant with increased cytotoxic activity. Masegi T; Kato A; Kitai K; Fukuoka M; Ogawa H; Ichikawa Y; Nakamura S; Watanabe N; Niitsu Y Jpn J Cancer Res; 1995 Jan; 86(1):72-80. PubMed ID: 7737913 [TBL] [Abstract][Full Text] [Related]
31. [Function, molecular structure and gene expression regulation of tumor necrosis factor and lymphotoxin]. Higashi N Nihon Rinsho; 1992 Aug; 50(8):1939-44. PubMed ID: 1331566 [TBL] [Abstract][Full Text] [Related]
32. Characterization of surface lymphotoxin forms. Use of specific monoclonal antibodies and soluble receptors. Browning JL; Dougas I; Ngam-ek A; Bourdon PR; Ehrenfels BN; Miatkowski K; Zafari M; Yampaglia AM; Lawton P; Meier W J Immunol; 1995 Jan; 154(1):33-46. PubMed ID: 7995952 [TBL] [Abstract][Full Text] [Related]
33. Human TNF mutants with selective activity on the p55 receptor. Van Ostade X; Vandenabeele P; Everaerdt B; Loetscher H; Gentz R; Brockhaus M; Lesslauer W; Tavernier J; Brouckaert P; Fiers W Nature; 1993 Jan; 361(6409):266-9. PubMed ID: 8380906 [TBL] [Abstract][Full Text] [Related]
34. Biological activities of human tumor necrosis factor-alpha and its novel mutants. Xi T; Shi X; Guo D; Dong X; Xu X; Zhu D Biochem Mol Biol Int; 1996 May; 38(6):1183-9. PubMed ID: 8739040 [TBL] [Abstract][Full Text] [Related]
35. TNF-Selectokine: a novel prodrug generated for tumor targeting and site-specific activation of tumor necrosis factor. Wüest T; Gerlach E; Banerjee D; Gerspach J; Moosmayer D; Pfizenmaier K Oncogene; 2002 Jun; 21(27):4257-65. PubMed ID: 12082613 [TBL] [Abstract][Full Text] [Related]
36. Structural and functional domains in human tumour necrosis factors. Goh CR; Porter AG Protein Eng; 1991 Apr; 4(4):385-9. PubMed ID: 1715560 [TBL] [Abstract][Full Text] [Related]
37. Specificity of molecular recognition learned from the crystal structures of TRAIL and the TRAIL:sDR5 complex. Cha SS; Song YL; Oh BH Vitam Horm; 2004; 67():1-17. PubMed ID: 15110168 [TBL] [Abstract][Full Text] [Related]
38. Identification of Grb2 as a novel binding partner of tumor necrosis factor (TNF) receptor I. Hildt E; Oess S J Exp Med; 1999 Jun; 189(11):1707-14. PubMed ID: 10359574 [TBL] [Abstract][Full Text] [Related]
39. Crystal structure of TNF-alpha mutant R31D with greater affinity for receptor R1 compared with R2. Reed C; Fu ZQ; Wu J; Xue YN; Harrison RW; Chen MJ; Weber IT Protein Eng; 1997 Oct; 10(10):1101-7. PubMed ID: 9488135 [TBL] [Abstract][Full Text] [Related]
40. Structure-based design and characterization of exocyclic peptidomimetics that inhibit TNF alpha binding to its receptor. Takasaki W; Kajino Y; Kajino K; Murali R; Greene MI Nat Biotechnol; 1997 Nov; 15(12):1266-70. PubMed ID: 9359109 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]